LLY

996.53

-0.83%↓

JNJ

242.58

-0.54%↓

ABBV

227.52

-0.04%↓

NVS

155.71

-4.3%↓

AZN

193.96

-1.65%↓

LLY

996.53

-0.83%↓

JNJ

242.58

-0.54%↓

ABBV

227.52

-0.04%↓

NVS

155.71

-4.3%↓

AZN

193.96

-1.65%↓

LLY

996.53

-0.83%↓

JNJ

242.58

-0.54%↓

ABBV

227.52

-0.04%↓

NVS

155.71

-4.3%↓

AZN

193.96

-1.65%↓

LLY

996.53

-0.83%↓

JNJ

242.58

-0.54%↓

ABBV

227.52

-0.04%↓

NVS

155.71

-4.3%↓

AZN

193.96

-1.65%↓

LLY

996.53

-0.83%↓

JNJ

242.58

-0.54%↓

ABBV

227.52

-0.04%↓

NVS

155.71

-4.3%↓

AZN

193.96

-1.65%↓

Начало・Списък с акции・ResMed Inc

ResMed Inc

Отворен

СекторЗдравеопазване

241.18 -2.68

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

236.49

Максимум

249.67

Ключови измерители
By Trading Economics
Приходи	44M 393M
Продажби	87M 1.4B
P/E Средно за сектора	24.993 66.845
Дивидентна доходност	0.89
Марж на печалбата	27.593
Служители	10,600
EBITDA	63M 566M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+18.86% upside

Дивиденти
By Dow Jones
Дивидентна доходност Средно за сектора	0.89% 2.25%
Следващи печалби	22.04.2026 г.
Следваща дата на дивидент	19.03.2026 г.
Следваща дата на екс-дивидент	7.05.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-371M 37B
Предишно отваряне	243.86
Предишно затваряне	241.18

Настроения в новините

By Acuity

17%

83%

15 / 351 Класиране в Healthcare

ResMed Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

10.03.2026 г., 20:38 ч. UTC

Печалби

Oracle Raises 2027 Sales Outlook Amid AI Demand, Restructuring

10.03.2026 г., 23:57 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

10.03.2026 г., 23:57 ч. UTC

Пазарно говорене

Risks Rising on Australian Bank Valuation Multiples -- Market Talk

10.03.2026 г., 23:47 ч. UTC

Пазарно говорене

Nikkei May Rise as Concerns About Energy Costs Ease -- Market Talk

10.03.2026 г., 23:37 ч. UTC

Придобивния, сливания и поглъщания

Yangzijiang Shipbuilding to Acquire Poseidon Stake for US$825.7M

10.03.2026 г., 23:37 ч. UTC

Придобивния, сливания и поглъщания

Yangzijiang Shipbuilding to Buy 10% Stake in Poseidon

10.03.2026 г., 23:37 ч. UTC

Придобивния, сливания и поглъщания

Yangzijiang Shipbuilding to Fund Deal With Internal Cash Resources

10.03.2026 г., 23:37 ч. UTC

Придобивния, сливания и поглъщания

Yangzijiang Shipbuilding to Buy Stake From Fairfax, Washington Family Affiliates

10.03.2026 г., 23:35 ч. UTC

Пазарно говорене

Значими събития в новините

Gold Edges Higher as It Faces Opposing Forces -- Market Talk

10.03.2026 г., 23:06 ч. UTC

Печалби

Oracle Raises 2027 Sales View as AI Demand Outpaces Supply -- Update

10.03.2026 г., 22:51 ч. UTC

Значими събития в новините

Deleted Tweet From Energy Secretary Sends Oil Markets on Another Wild Ride -- Updated

10.03.2026 г., 21:39 ч. UTC

Придобивния, сливания и поглъщания

Bill Ackman Has a Stroke of Genius. Buy His New Fund and Get Shares of His Pershing Square IPO. -- Barrons.com

10.03.2026 г., 21:21 ч. UTC

Печалби

Oracle Stock Jumps on Earnings Beat. Its Cloud Business Is Taking Over. -- Barrons.com

10.03.2026 г., 21:15 ч. UTC

Печалби

Franco-Nevada: 2026 Total GEOs Expected to Range From 510,000 to 570,000 Ounces

10.03.2026 г., 21:15 ч. UTC

Придобивния, сливания и поглъщания

Paramount Skydance's Stock Fades. The Warner Bros. Merger Will Take Years to Pay Off, BofA Says. -- Barrons.com

10.03.2026 г., 21:14 ч. UTC

Печалби

Franco-Nevada: Methodology Replaces Previous Variable GEO Conversion Ratios Based on Prevailing Market Prices

10.03.2026 г., 21:13 ч. UTC

Печалби

Franco-Nevada: Beginning in 2026, Company Will Be Adopt Fixed GEO Conversion Ratios Based on the Pricing Assumptions Outlined in 2026 Guidance

10.03.2026 г., 21:12 ч. UTC

Печалби

Franco-Nevada 4Q Rev $597.3M >FNV

10.03.2026 г., 21:12 ч. UTC

Печалби

Franco-Nevada 4Q EPS $1.90

10.03.2026 г., 20:57 ч. UTC

Печалби

Oracle Stock Jumps on Earnings Beat -- Barrons.com

10.03.2026 г., 20:50 ч. UTC

Пазарно говорене

Печалби

Tech, Media & Telecom Roundup: Market Talk

10.03.2026 г., 20:44 ч. UTC

Печалби

Oracle Stock Jumps on Earnings Beat -- Barrons.com

10.03.2026 г., 20:34 ч. UTC

Пазарно говорене

Печалби

Global Equities Roundup: Market Talk

10.03.2026 г., 20:34 ч. UTC

Пазарно говорене

Печалби

Oracle Building More Software for Less Money After Restructuring -- Market Talk

10.03.2026 г., 20:23 ч. UTC

Печалби

Oracle Stock Jumps on Earnings Beat -- Barrons.com

10.03.2026 г., 20:16 ч. UTC

Печалби

NIO Stock Jumps After Earnings. How the EV Maker Delivered a Surprise Profit. -- Barrons.com

10.03.2026 г., 20:14 ч. UTC

Печалби

Oracle Has Not Yet Initiated At-The-Market Equity Portion of Financing Program >ORCL

10.03.2026 г., 20:14 ч. UTC

Печалби

Oracle Said In February It Intends to Raise Up to $50 B Dollars in Debt and Equity Financing >ORCL

10.03.2026 г., 20:13 ч. UTC

Печалби

Oracle Raised $30 B Through Combination of Investment Grade Bonds and Mandatory Convertible Preferred Stk Within Days of Feb Announcement >ORCL

10.03.2026 г., 20:12 ч. UTC

Печалби

Oracle Stock Jumps on Earnings Beat -- Barrons.com

Сравнение с други в отрасъла

Ценова промяна

ResMed Inc Прогноза

Ценова цел

By TipRanks

18.86% нагоре

12-месечна прогноза

Среден 300.64 USD 18.86%

Висок 345 USD

Нисък 265 USD

Според 13 анализатори от Wall Street, предложили 12-месечна ценова цел за ResMed Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

13 ratings

Купи

Задържане

Продай

Според 13 анализатори, дали борсови рейтинги на ResMed Inc през последните 3 месеца.

Настроение

By Acuity

15 / 351 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.